| Style | Citing Format |
|---|---|
| MLA | Hejazi MJ, et al.. "S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse." Medical Oncology, vol. 39, no. 8, 2022, pp. -. |
| APA | Hejazi MJ, Tamaddon G, Kohan N, Sharifi M (2022). S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse. Medical Oncology, 39(8), -. |
| Chicago | Hejazi MJ, Tamaddon G, Kohan N, Sharifi M. "S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse." Medical Oncology 39, no. 8 (2022): -. |
| Harvard | Hejazi MJ et al. (2022) 'S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse', Medical Oncology, 39(8), pp. -. |
| Vancouver | Hejazi MJ, Tamaddon G, Kohan N, Sharifi M. S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse. Medical Oncology. 2022;39(8):-. |
| BibTex | @article{ author = {Hejazi MJ and Tamaddon G and Kohan N and Sharifi M}, title = {S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse}, journal = {Medical Oncology}, volume = {39}, number = {8}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Hejazi MJ AU - Tamaddon G AU - Kohan N AU - Sharifi M TI - S100a8 Inhibition in Leukemic Lymphoblasts Induces Sensitivity to Chemotherapy and Inhibition of Disease Relapse JO - Medical Oncology VL - 39 IS - 8 SP - EP - PY - 2022 ER - |